The Walter Sisulu University and North-West University in South Africa unveiled the results of their preclinical trials for a combination vaccine against tuberculosis (TB) and Covid-19. Reflecting on the revolutionary nature of this vaccine, Prof Depfenhart shared: “DNA vaccines have incredible potential due to their stability and adaptability. The key deliverable of the study, which was carried out at the high-security biosafety laboratory (BSL3) of the preclinical imaging facility of the South African Nuclear Medicine Research Infrastructure (SANuMeRI) housed at NECSA (South African Nuclear Energy Corporation), was survival. This novel approach, developed by Prof Depfenhart, could be groundbreaking and may well explain the vaccine’s notable efficacy against TB. Preparations for discussions with the South African Health Products Regulatory Authority (SAHPRA) are underway to determine the requisite standards and protocols.

Source: News Business Ethiopia August 25, 2023 15:49 UTC